BIO-key International, Inc. (BKYI) Q1 2026 Earnings Call Transcript
BIO-key International, Inc. (BKYI) Q4 2025 Earnings Call Transcript
BIO-key International, Inc. ( BKYI ) Q3 2025 Earnings Call November 14, 2025 10:00 AM EST Company Participants Michael DePasquale - Chairman & CEO Cecilia Welch - Chief Financial Officer Conference Call Participants William Jones Jack Vander Aarde - Maxim Group LLC, Research Division Presentation Operator Good morning, everyone. Thank you for standing by, and welcome to BIO-key International's Third Quarter 2025 Conference Call.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| MM Mark Mowrey Signature Resources Capital Management LLC | 100 | $539 | $391 | -$148 | -27.46% |
| IT Services Industry | Information Technology Sector | Michael W. DePasquale CEO | OTC PINK Exchange | 09060C606 CUSIP |
| US Country | 41 Employees | 25 Jul 1997 Last Dividend | 30 Apr 2026 Last Split | 14 Feb 1997 IPO Date |
BIO-key International, Inc., originally known as SAC Technologies before its renaming in 2002, is a pioneer in developing and offering advanced fingerprint identification biometric technology and software solutions. Based in Wall, New Jersey, and founded in 1993, BIO-key International extends its technological services to a diverse range of sectors including commercial, government, and education both within the United States and on a global scale. The company is committed to delivering enterprise-ready identity access management solutions, aiming to enhance security protocols for its clientele's workforces, student bodies, and partner networks. Through its innovative approaches, BIO-key International, Inc. strives to facilitate more secure and collaborative environments for all its customers, leveraging the latest in biometric technologies to meet the evolving demands of identity verification and access management.